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lungs by representing the hypothesized processes involved in the form of a mathematical model.
METHODS

Isolated Lung Preparation
The isolated rabbit lung preparation used has been described previously (3, 10) . Each of 22 New Zealand White rabbits [2.51 Ϯ 0.23 (SD) kg body wt] was given chlorpromazine hydrochloride (25 mg/kg im) followed by pentobarbital sodium (15-20 mg/kg iv). A carotid artery catheter was inserted for heparinization (1,200 IU/kg) followed by exsanguination. The chest was opened, and cannulas were placed in the pulmonary artery, left atrium, and trachea. The cannulated lungs were removed and suspended vertically from the trachea, with the arterial and venous cannulas connected to a temperature-controlled (37°C) recirculating perfusion system primed with a physiological salt solution (PSS) containing (in mM) 4.7 KCl, 2.51 CaCl 2 , 1.19 MgSO 4 , 2.5 KH 2 PO 4 , 118 NaCl, 25 NaHCO 3 , and 5.5 glucose and, in most cases, either 5% BSA (referred to as PSS-albumin) or 5% dextran (average mol wt 74,200) (referred to as PSSdextran). The perfusate was pumped (Masterflex roller pump) into the pulmonary artery from a reservoir into which the perfusate drained from the left atrium. The first 200 ml to pass through the lungs were used to clear the lungs of residual blood and were discarded before commencing recirculation. The standard flow rate was 200 ml/min, with the flow rate adjusted temporarily according to the experimental protocol as indicated in Bolus Injections. Pulmonary venous pressure was set equal to pleural pressure between adjustments required for a particular experimental protocol. Pulmonary arterial and left atrial pressures, measured relative to the level of the left atrium, were monitored continuously. The lungs were ventilated with a gas mixture of ϳ17% O 2 -5% CO 2 -balance N 2 at a frequency of 11 breaths/min, with end-inspiratory and end-expiratory pressures of ϳ6 and 1 Torr, respectively, maintained with water overflow valves. The resulting perfusate PO 2 , PCO 2 , and pH were 123 Ϯ 4.6 (SD) Torr, 36.2 Ϯ 2.9 Torr, and 7.40 Ϯ 0.05, respectively.
To measure the venous effluent indicator concentration versus time curves, the venous effluent could be diverted into the sample tubes of a Gilson-Escargot fraction collector modified to sample at Յ6.67 samples/s. For experiments in which TBO was studied in PSS-albumin-perfused lungs, the venous effluent tubing passed through a previously described photodetector (40) , measuring optical absorbance at wavelengths of 490 and 590 nm, before flowing into the fraction collector tubes. Each fraction collector tube contained 20 µl of 0.8 mM potassium ferricyanide solution so that complete oxidation of any reduced MB (MBH) or TBO (TBOH) in the effluent would occur before the absorbance was measured. Thus total MB, MBH ϩ oxidized MB (MB ϩ ), total TBO, or TBOH ϩ oxidized TBO (TBO ϩ ) concentration in the venous effluent was measured in the fraction collector tubes. The photodetector measured TBO ϩ rapidly enough after leaving the lung that autoxidation of any TBOH present was small. FITC-dextran, which was also measured by the photodetector, was included in the bolus for the purpose of determining the transport function between the two sampling sites as indicated in Bolus Injections.
Bolus Injections
To measure the disappearance of MB ϩ , TBO ϩ , or TBOH from a bolus during passage through the lungs, the ventilation was halted in end expiration and the venous outflow was diverted into the fraction collector. A 0.9-ml bolus containing reference indicators 125 I-labeled human serum albumin (ϳ0.09 µCi/ml) and/or FITC-dextran (1.5 mg/ml, average mol wt 2,000) and test indicators MB ϩ , TBO ϩ , or TBOH (0.1-0.15 nmol/ml) was then introduced into the arterial inflow tubing via an injection loop. Consecutive 2-ml samples were collected at a rate and duration appropriate for the flow rate used. The first sample was used as a background reference sample. Measured quantities of the injectate solution were added to the next three samples. All of these samples emerged in the venous effluent before the appearance of the injected indicators, and they were used as standards for determining the effluent concentrations of 125 I, FITC, MB ϩ , or TBO ϩ as fractions of their injected concentrations. A 1-ml aliquot of each collected sample was used to determine 125 I concentration by gamma scintillation counting. The remainder was analyzed spectrophotometrically. The photodetector output was calibrated with known concentrations of FITC, TBO ϩ , or MB ϩ in the perfusate solution. Eight percent of the TBO signal at 590 nm was measured at 490 nm, with no detectable FITC signal at 590 nm. The reference indicator recoveries based on the standards were not significantly different from 100%. For MB, the perfusate was PSS-dextran. For TBO, both PSS-dextran and PSSalbumin were used.
To prepare the TBOH injectates, 3 ml of the respective perfusate containing 160 µM TBO, 1.5 mg FITC-dextran and 200 µM NADH were added to a test tube having two ports. The mixture was bubbled through one of the ports for 10 min with 5.8% CO 2 in N 2 to deoxygenate while maintaining the pH at 7.4. Diaphorase (0.2 U in 0.02 ml) was then added to the solution under anoxic conditions. After the disappearance of blue color from the solution, the ports were sealed and low-dead space syringes were filled with the injectate directly from the sealed tube. The injection loop was prefilled with 3 ml of deoxygenated perfusate just before the addition of the 0.9-ml TBOH injectate.
At the end of each experiment, the lungs were removed and the pulmonary arterial and left atrial cannulas were connected directly together. Boluses containing the 125 I-labeled albumin and FITC-dextran were injected and fraction collector samples and photodetector output were collected at each flow rate used in the experiment. At least one such bolus also included the respective thiazine compound. The data obtained from these samples were used to measure the part of the bolus transit time and dispersion that was caused by the injection, tubing, and sampling system and to affirm that any separation between the thiazine test indicator concentration curves and the reference indicator concentration curves was caused only by passage through the lungs and not some interaction with the perfusion system connected to the lungs.
To measure the indicator concentration versus time curves over a range of flow rates, the first step was to raise the flow rate to the highest level to be used in the experiment, with the left atrial pressure set equal to atmospheric pressure at the level of the left atrium. The resulting arterial pressure divided by 2 was the value at which the average of the arterial left atrial pressure was set for each of the lower flow rates by adjusting the height of the reservoir. This was done so that the vascular volume was approximately the same at each flow rate. The flow rate was then set at ϳ200, 400, 600, or 800 ml/min in TBO experiments or 50, 100, 200, or 300 ml/min in MB experiments, and a bolus was injected and samples collected as indicated above. Injections were then made at two or three of the other designated flow rates in similar fashion.
To determine whether dextran in the perfusate might have any influence on TBO or MB disposition in the lungs, after the above-described protocol had been completed in one of the lungs from the TBO and MB groups perfused with PSS-dextran, the perfusate was changed to PSS with neither dextran nor albumin. Then a TBO ϩ or MB ϩ bolus (also dextran free) was injected at a flow rate of 800 or 300 ml/min, respectively. Also, in one lung perfused with PSSdextran the photodetector was included to confirm that effluent MBH and TBOH concentrations were below detectable levels when there was no plasma albumin in the perfusate.
Additional Measurements
The equilibrium binding of TBO ϩ and TBOH to BSA was measured by ultrafiltration using the Amicon MPS-1 micropartition system with a YM30 membrane at room temperature as previously described (3) . The concentration of TBO ϩ or TBOH was 12 µM in phosphate-buffered (pH 7.4) 0.9% NaCl solution containing 5% BSA. TBOH was prepared by adding 0.5 µmol sodium hydrosulfite/ml of TBO ϩ solution. TBOH was measured after reoxidation to TBO ϩ . The albuminbound fractions were 59 and 79% for TBO ϩ and TBOH, respectively.
The apparent octanol-to-water partition coefficient for TBOH and TBO ϩ at room temperature was determined as previously described (10) by using a concentration of 10.4 µM TBO ϩ or TBOH in 0.1 M phosphate buffer (pH 7.4). TBOH was prepared as indicated in Bolus Injections for the ultrafiltration studies. The values of the partition coefficients were 0.95 and 10.3 for TBO ϩ and TBOH, respectively. The previously reported values for MB ϩ and MBH were 0.22 and 16, respectively (10) .
To determine the TBOH autoxidation rate, TBOH was prepared in a manner similar to the TBOH injectate described above. TBO and NADH (final concentration of 160 µM for both) were added to tubes containing 3 ml Hanks' balanced salt solution and 10 mM HEPES at pH 7.4 with or without 5% BSA or 5% dextran. Each solution was bubbled with N 2 for 10 min, and diaphorase (0.2 U) was added. The resulting TBOH solution (0.1 ml) was added to a spectrophotometric cuvette containing 2 ml Hanks'-HEPES buffer with or without 5% BSA or 5% dextran at pH 7.4 and equilibrated with atmospheric PO 2 . Absorbance at 590 nm was recorded at 5-s intervals for 3 min in a Beckman DU 7400 spectrophotometer at 37°C.
RESULTS
Experimental Results
The pressure, flow, and volume data reflecting the conditions under which the injections were carried out are given in Tables 1 and 2 . The average pressures and vascular volumes were higher for the TBO than the MB experiments because of the higher flow rate range covered. The injections themselves had no detectable effect on perfusion pressures, suggesting that any effects that these compounds might have on vascular tone were below the level of detectability in these studies.
Examples of graphs of indicator concentrations normalized to their respective injected amounts versus time, for the various combinations of PSS-dextran, PSS-albumin, MB ϩ , TBO ϩ , and TBOH and at different flow rates, are shown in Figs. 1-5. With PSS-dextran perfusion, only the oxidized forms were detected in the venous effluent. The presence of TBOH in the effluent after TBO ϩ injections when the lungs were perfused with PSS-albumin is reflected by the fact that the total TBO (TBOH ϩ TBO ϩ ) concentrations were higher than the concentrations of TBOϩ alone (Fig. 3) . The fractions of MB ϩ and TBO ϩ that disappeared from the PSS-dextran and PSS-albumin perfusates on passage through the lungs are summarized as extractions in Fig. 6 . The TBO ϩ extractions were higher than the MB ϩ extractions even though the flow rate range was also higher for TBO ϩ . The extraction of TBO ϩ from PSSalbumin was lower than from PSS-dextran, reflecting the effects of the TBO ϩ -BSA binding. When the lungs were perfused with PSS with neither albumin nor dextran, the effluent TBO ϩ and MB ϩ were indistinguishable from those when the lungs were perfused with PSS-dextran, indicating that the dextran had no detectable effect on TBO ϩ or MB ϩ extraction. When TBOH rather than TBO ϩ was injected with PSS-albumin as the perfusate, the effluent TBOH concentration curves tended to be displaced to the right in comparison to the reference indicator or to the TBO ϩ curves after TBO ϩ injection (Fig. 4) . This difference reflects the tissue distribution of the TBOH (see DISCUSSION) . When TBOH was injected with PSS-dextran as the perfusate, the TBOH almost completely disappeared from the perfusate (Fig. 5 ).
Further evaluation of these results was carried out by expressing the hypothesized interactions between these thiazine compounds and the lung tissue in the following model.
Model
The thiazine dyes are assumed to participate in the following associations and reactions within the perfusate and tissue.
Stoichiometric equations. 
In Perfusate
In Tissue 2) When the plasma protein (P) was present in the perfusate, the equilibration between P and B ϩ or BH was rapid relative to the capillary transit time (t c ).
3) The endothelial cell reduction of B ϩ mediated by E was irreversible. 4) The association of B ϩ with Z was rapid relative to t c . 5) The equilibration of BH between Q c and Q t with tissue to perfusate partition coefficient was rapid relative to t c . 6) The PO 2 and [DH] were constant under the study conditions. SINGLE CAPILLARY ELEMENT. Under the assumption of rapid equilibration between the free and plasma protein-bound B ϩ and BH
where K 1 ϭ k Ϫ1 /k 1 and K 2 ϭ k Ϫ2 /k 2 are the plasma protein equilibrium dissociation constants for B ϩ and BH, respectively. Under the assumption of rapid equilibration between B ϩ and Z
where 
where
The model parameters are Q F ϭ Q f /␣ 1 (ml), which is the measure of the magnitude of the rapidly equilibrating nonspecific interactions of B ϩ with the tissue; Q T ϭ Q t /␣ 2 (ml), which is the measure of the magnitude of the rapidly equilibrating partitioning of the BH between tissue and perfusate; K red ϭ (Ek r1 ϩ Ek r2 [P]/K 1 )/␣ 1 (ml/s), which is the measure of the B ϩ reduction rate; K seq ϭ [A]k 4 Q T (ml/s), which is the measure of the BH sequestration rate within the tissue; and k o (s Ϫ1 ), which is the rate of autoxidation of BH within the perfusate.
Whole organ. To construct an organ model from the single capillary element model, the distribution of pulmonary capillary transit times [h c (t)] needs to be taken into account (4, 29) . Previously, we (5) estimated that for normal rabbit lungs in this perfusion system, the pulmonary capillary mean transit time (t c ) was ϳ44% of the total vascular mean transit time ( t ), the relative dispersion of h c (t) (RD c ϭ c /t c ) was ϳ0.9, and the skewness coefficient of h c (t)
For the present analysis, we used these values to approximate h c (t) using a shifted random walk function, which is a probability density function whose functional values are determined by these three moments as previously described (2).
The organ reference indicator outflow concentration vs. time curve [C R (t) ϭ (q/F)h c (t)*h n (t), where * is the convolution operator, q is the mass of the injected indicator, F is the total flow through the organ, and h n (t) is the noncapillary (arteries, veins, connecting tubing and the injection system) transit time distribution] was obtained. The h n (t) was also represented by a shifted random walk function whose parameters were specified by iteratively convolving a trial h n (t) with h c (t) until the optimal least-squares fit to C R (t) was obtained (2).
To estimate model parameters from the data from each injection, Eqs. 9 and 10 were solved numerically for the appropriate boundary conditions (given in Estimation of Model Parameters for Specific Experiments) using the finite-difference method at each iteration of a Levenberg-Marquardt optimization routine (4, 31) . The solution is for a single capillary element with C in (t) as the capillary input concentration curve. The model solution for a single capillary having the maximum capillary transit time also provides the output for all capillary transit times between the minimum and maximum capillary transit times (4). To provide the whole organ output for vascular reference indicator [C R (t)], and test indicator [C(t)], the outputs for all transit times are summed, each weighted according to h c (t) (4) .
Autoxidation of BH in arteries, veins, and connecting tubing. Because BH autoxidation can occur outside the capillary region within the conducting arteries and veins and the tubing connecting the lungs to the injection and sampling sites, this autoxidation was also 
which can be analytically solved for [BH](,t) and [B ϩ ](,t), where x ϭ is the inlet to either the capillaries or to the photodetector ](x,t), respectively, at either the injection site or the capillary outlet, and t o is the mean transit time either between the injection site and the capillary inlet or between the capillary outlet and the sampling site. The values of k o for TBOH were 2.73 ϫ 10 Ϫ2 and 2.45 ϫ 10 Ϫ2 s Ϫ1 in PSS-albumin and PSS-dextran, respectively, estimated from the data in Fig. 7 as indicated in the APPENDIX.
Estimation of Model Parameters for Specific Experiments TBO ϩ injections in lungs perfused with PSS-albumin.
In the lungs perfused with PSS-albumin, the outflow concentrations of TBO ϩ and total TBO (TBOH ϩ TBO ϩ ) were measured at different sampling sites as described in METHODS. The first step in the model interpretation of these data was to reconstruct the TBO ϩ curve measured by the photodetector as it would have appeared had it been measured at the fraction collector sampling site where the total TBO was measured. This was carried out as follows. The photodetector concentration curves acquired at 25 Hz for TBO ϩ and FITC were converted to discretely sampled curves with the same sampling time interval as the sample collector time interval using a infinite impulse response filter and decimator. The transfer function from the photodetector sampling site to the fraction collector was obtained by numerically deconvolving (13) the photodetector FITC tubing curve and the 125 I fraction collector tubing curve. The resulting transfer function was then convolved with the discretized photodetector TBO ϩ curve to estimate the TBO ϩ curve at the sample collector site.
For a given bolus injection, the model was fit to the measured total TBO and the reconstructed TBO ϩ data as follows. , respectively, at the capillary outlet, and t o is the mean transit time between the capillary outlet and the photodetector. For these data, the identifiable model parameters are Q F , Q T , K red , and K seq , with k o fixed at the value estimated from the data in Fig. 7 .
TBO ϩ and MB ϩ injections in lungs perfused with PSS-dextran. For TBO ϩ and MB ϩ injections in lungs perfused with PSS-dextran, because [P] ϭ 0, ␣ 1 ϭ 1, Q F ϭ Q f , and K red ϭ Ek r1 and Eqs. 9 and 10 simplify to
The model fit to the TBO ϩ or MB ϩ data from each injection was obtained by solving Eq. 14 with the initial 
TBOH injections in lungs perfused with PSS-albumin or PSS-dextran.
For the TBOH injection data, the model was fit to the total TBO data from each injection by solving Eqs. 9 and 10 with the initial conditions
The above boundary conditions account for the autoxidation of the TBOH during transit time t o upstream from the capillary inlet. For the PSS-albumin data, the identifiable model parameters are Q T and K seq , with Q F and K red fixed to the mean values estimated from the TBO ϩ injections given in Table 3 . For the PSS-dextran data, the identifiable model parameter is Q T , with Q F and K red fixed to the mean values estimated from the TBO ϩ injections given in Table 4 and K seq fixed to the value given in Table 5 . Figs. 1-5 , and Tables 3-6 summarize the model parameter values. Examples of the sensitivity functions i S(t) (6) obtained for the optimized parameters are given in Figs. 8 and 9 for TBO ϩ and total TBO after TBO ϩ injections into the PSS-albumin perfusate and for TBOH after TBOH injections into the PSS-albumin perfusate, respectively. For the ith model parameter, i , S i (t) ϭ ѨC(t)/Ѩ i , where C(t) is the calculated test indicator effluent concentration. S i (t) was approximated by the change in C(t) resulting from a 1% change in i divided by the change in i (6) . When S i (t) is multiplied by the value of the parameter estimate, i , the relative amplitude of this function for each respective parameter provides an indication of the relative contribution of the parameter to the model fit to the data at a given time. Comparison of the respective shapes of their respective i S i (t) reveals the degree to which any pair of parameters is correlated. Interpretation with respect to the individual parameters is discussed below.
Model Results
Examples of the model fits to the data are included in
DISCUSSION
Both TBO ϩ and MB ϩ were extracted from the PSSdextran perfusate on passage through the lungs. However, the TBO ϩ extractions were considerably greater than those of MB ϩ . The TBO ϩ extractions were Ͼ70% even at flow rates above those reported for the normal resting pulmonary flow rate for rabbits in this size range (276-540 ml/min; Ref. 38) . This is in contrast to MB ϩ , for which the extraction was only ϳ15% at only 300 ml/min. The role of reduction in the extraction of MB ϩ during its passage through the lungs was demonstrated previously (10) . The fact that TBO ϩ was also reduced during passage through the lungs was revealed only when albumin was present in the perfusate. This is because the highly lipophilic TBOH has such a high solubility in the lung tissue that, with no protein in the perfusate, the effluent contained little trace of any TBOH that might have been formed. The presence of TBOH in the effluent when the lungs were perfused with the albumin-containing perfusate resulted from its affinity for the albumin, which offset its affinity for the tissue. The present study does not identify the location of the TBO ϩ reduction. However, a previous study, with a TBO-containing polymer that could not enter the cells, established the ability of endothelial cells to reduce TBO ϩ on the cell surface (12) . Therefore, it appears likely that this surface reduction accounts for at least part of the disappearance of the relatively hydrophilic TBO ϩ within the lungs.
Another key observation was that the extractions of both MB ϩ and TBO ϩ were inversely proportional to flow rate to the extent that variations in the reduction rate parameter, K red , with flow rate were small over the fairly wide range of flow rates studied. The implication of this observation is that the reduction rate, rather than the rate of convective supply of the indicators, dominates the extraction. One might visualize the reduction reaction as a barrier that must be traversed for TBO or MB to enter the tissue. In the terminology commonly used in the indicator dilution field, their extractions tend toward ''barrier-limited'' rather than ''flow-limited'' (23) behavior. The isopleths in Fig. 6 are for the most parsimonious nested version of the model developed herein, commonly referred to as the CroneRenkin model (7), for which the solution for K red is K red ϭ ϪF ϫ ln(1 Ϫ extraction). For this model, barrier-limited extraction as a function of flow rate produces curves parallel to these isopleths. Thus the extent to which the TBO ϩ and MB ϩ extraction data parallel these isopleths may be thought of as a preliminary indication of the extent to which the extractions correspond to barrier-or reaction-limited behavior. The alternative of flow-limited behavior would produce horizontal lines in Fig. 6 . As discussed below, the inclusion of additional detail in the model can explain most of the deviation from the Crone-Renkin model prediction observable in Fig. 6 .
The model developed herein to interpret the test indicator probe disposition represents a simplistic view of the overall processing of the indicators by the lung.
Steps have been left out of the stoichiometric equations that could be added if warranted by experimental manipulations of the relevant variables in future studies. The attempt was to accommodate aspects of the tissue disposition of TBO and MB predicted by previous studies under the present range of experimental conditions. Even so, the model is fairly complex, having several parameters that were either input, i.e., ob- Values are means Ϯ SE; n ϭ 4 experiments. PSS, physiological salt solution; K red , reduction rate parameter defined by Eq. 9; Q F , measure of magnitude of rapidly equilibrating nonspecific interactions of oxidized toluidine blue O (TBO ϩ ) with tissue as defined by Eq. 9; Q T , measure of magnitude of rapidly equilibrating partitioning of reduced TBO (TBOH) between tissue and perfusate as defined by Eq. 10; K seq , TBOH sequestration rate parameter defined by Eq. 10. CV, coefficient of variation between model fit and data. Values are means Ϯ SE; n ϭ 8 experiments. K red , reduction rate parameter defined by Eq. 14; Q F , measure of magnitude of rapidly equilibrating nonspecific interactions of TBO ϩ with tissue as defined by Eq. 14. Values are means Ϯ SE; n ϭ 2. Q T , measure of magnitude of rapidly equilibrating partitioning of TBOH between tissue and perfusate as defined by Eq. 10; K seq , TBOH sequestration rate parameter defined by Eq. 10. tained from sources separate from the data from an individual bolus, or estimated by fitting the model to the bolus data. The fitted parameters include terms that are not separately identifiable without a more complex set of experimental conditions. Furthermore, all of the model parameters do not contribute equally to the fits to the data from each type of experiment performed or from the same type of experiment but at different flow rates. In fact, the effects of some phenomena represented in the model are not detectable in all experimental conditions. To help put this in perspective, the sensitivity functions for the model fits to the TBO ϩ and total TBO data from the PSS-albumin experiments are shown in Fig. 8 . The sensitivity functions reveal the extent, and the time epoch, to which the optimized model parameters make their contributions to the fit of the model to the data (2, 6) . Thus the dominant role of K red in the fits to the TBO ϩ data, especially near the peak of the reference indicator curve can be seen in Fig. 8 . Q F has most of its influence at early and late times with respect to the reference indicator passage and little influence near the peak of the reference indicator. The very different shapes of the sensitivity functions for these two parameters also imply their relatively independent contributions to the model fit. This is expressed quantitatively for the examples in Fig. 8 by the fact that the correlations (3, 26) between Q F and K red were Ͻ0.34 at all flow rates studied. The physical counterpart of Q F is not certain. It may include a volume into which at least some TBO ϩ diffuses before its reduction, possibly inside the cell. However, a compound that binds to plasma protein may likewise have an affinity for molecules on the cell surface, presumably including plasma albumin itself associated with the endothelial surface or glycocalyx (2, 43, 44) .
The contribution of Q T to the fit to the TBO ϩ data is small and barely detectable on the same scale as S(t) for K red and Q F at the high end of the range of flow rates studied. On the other hand, when the model is fit to the total TBO data, the contribution of Q T is substantial and the impact of K seq , which does not contribute to the TBO ϩ fit, is evident.
K red , Q F , and Q T are the dominant parameters in the PSS-albumin experiment. The sensitivity functions for the MB ϩ and TBO ϩ experiments in the PSS-dextranperfused lungs are not shown because they are qualitatively similar to those for TBO ϩ in PSS-albumin sensitivity functions, but without Q T . Thus, for the PSSdextran experiments, wherein the returning flux of TBOH is insignificant, K red and Q F are the controlling parameters.
The sensitivity functions for the TBOH injected into PSS-albumin reveal the importance of Q T and K seq (Fig.  9 ). TBOH is a lipophilic amine compound, and except for the small effects due to autoxidation, the model for its tissue disposition is the same as the general model developed for lipophilic amines in a previous study (3) . The reasons for variations in the model parameters Q F , Q T , and K seq for the MB ϩ , TBO ϩ , and TBOH injections with flow rate have been discussed previously (2, 3) . In essence, the phenomenon occurs because two or more reversible processes having different dissociation rate Values are means Ϯ SE; n ϭ 8 injections for 50, 100, and 200 ml/min and 6 for 300 ml/min. MB ϩ , oxidized methylene blue; K red , reduction rate parameter defined by Eq. 14; Q F , measure of magnitude of rapidly equilibrating nonspecific interactions of TBO ϩ with tissue as defined by Eq. 14.
constants, which are not sufficiently different for the processes to be distinguishable in the data obtained at a given flow rate, become lumped into one process in an MID model. When the flow rate is changed the relative contribution of each process to the data also changes, and the lumped parameter(s) representing these processes will be flow rate dependent. One conclusion with regard to the present study is that the reversible processes represented by Q F and Q T include distributed dissociation rate constants not explicitly represented in the model or evident in the data from a single flow rate (3). Likewise, the term sequestration applied to K seq means that the dissociation rates are long relative to the capillary transit time, not that the processes are necessarily irreversible.
The overall tissue disposition of TBO and MB apparently involves the reduction, and nonspecific binding of the oxidized forms, and the partitioning of the reduced forms between tissue and perfusate volumes as represented in the model. However, it has also been demonstrated in endothelial cells in culture that TBOH can be reoxidized and sequestered within the cells (33) . The sequestration apparently occurs because the oxidized forms of the thiazines are strongly polar, cationic (14) , relatively hydrophilic compounds and thus relatively membrane impermeant. Thus the oxidized forms cannot so readily escape their intracellular site(s) of oxidation, and partitioning in accordance with membrane potentials of the sequestering intracellular organelle(s) may play a role as well (27) . This sequestration contributes relatively little to the disposition of the TBO within the time frame of the bolus transient in normal lungs, as evidenced by the small value of K seq (Ͻ3 ml/s) in comparison to K red (Ͼ17 ml/s). However, preliminary results suggest that the sequestration rate may be increased in the lungs of rats adapted to hyperoxia, to the extent that it can have a substantial influence even during the bolus transient (39) . Thus K seq may take on greater significance in conditions in which intracellular reactions that reoxidize the reduced thiazine compounds may be affected.
General aspects of the sensitivity to the input parameters controlling bolus dispersion and capillary transit times have been discussed at length previously (4, 29) . The main reason for the larger values of K red obtained from the present model, reported in Tables 3, 4 , and 6, in comparison to the Crone-Renkin model predictions, which can be read in Fig. 6 , is the effect of capillary perfusion heterogeneity not included in the CroneRenkin model. One of the important reasons for parameterizing the data using the particular modeling approach described herein is the potential for preventing a change in perfusion heterogeneity from being aliased by a change in tissue parameters (4) . In the present study, the capillary transport function was assumed to be typical of the normal rabbit lung (5). However, in future studies of abnormal conditions, in which that assumption would not necessarily hold, inclusion of a flow-limited indicator such as labeled water in the bolus would provide the necessary information to account for a change in perfusion heterogeneity as discussed previously (4, 42) .
Another input parameter was the TBOH autoxidation rate (k o ), which was included to evaluate the assumption that the TBO ϩ data measured on-line can represent the TBO ϩ exiting the lung capillaries without contamination by autoxidation of effluent TBOH. The autoxidation turned out to be a minimal contributor to the on-line signal as can been seen in Fig. 10 , in which a model simulation of the effluent TBO ϩ , the effluent Fig. 9 . Sensitivity functions [S(t)] for the 2 parameters Q T and K seq from model fit to TBOH concentration data obtained after injection of TBOH into a lung perfused with PSS-albumin. Fig. 10 . Simulated effluent concentration vs. time curves after injection of TBO ϩ in a lung perfused with PSS-albumin. Curves are for TBO ϩ that passed through lungs without being reduced, TBOH generated by reduction of TBO ϩ , and TBO ϩ resulting from autoxidation within perfusate of TBOH formed in lungs.
TBOH, and the TBO ϩ resulting from autoxidation of effluent TBOH is shown for the lowest flow rate in the range studied (i.e., the flow rate providing the longest time for autoxidation to occur).
As indicated above, it was the presence of the albumin in the perfusate that revealed the reduction of TBO ϩ . Because even without albumin binding the MB ϩ extraction was low, we did not pursue the consequences of including albumin in the perfusate for MB uptake. On the other hand, TBO uptake was high enough to provide an adequate window for examining the influence of albumin binding. As expected from the fact that TBO ϩ associates with plasma albumin, the presence of albumin decreased the rate of TBO ϩ disappearance from the perfusate. However, the decrease was not as great as predicted from the TBO ϩ -BSA binding measured by ultrafiltration, under the assumption that only the free TBO participates in the uptake process. Under the assumption that the BSA-bound TBO ϩ is not reducible and using the average values of K red from the PSS-albumin and PSS-dextran experiments, the predicted albumin binding would be only 39%, instead of the 59% obtained by ultrafiltration. This difference between the two is a common observation for the extraction of protein-bound substrates in the liver (45, 48) and other organs (25, 41) . Several explanations have been proposed, including the possibility that albumin-bound ligand or substrate can interact directly with the cell surface process. Thus, for the TBO interaction with the pulmonary endothelium, it is conceivable that binding to BSA slows but does not prevent TBO reduction. This would be consistent with the observation that TBO covalently bound to an acrylamide polymer is reduced on the surface of pulmonary arterial endothelial cells in culture (12) . It would also be consistent with the notion that endogenous electron acceptors such as the quinonoid forms of antioxidants such as tocopherylquinone and ubiquinone associated with plasma proteins such as lowdensity lipoproteins might be reducible without dissociating (11) .
A similar analysis can be carried out on the data from the TBOH injections, from which albumin binding can be predicted by comparing the Q T obtained in the PSS-dextran (average value 483 ml) and PSS-albumin experiments (Table 5; Ref. 3). The TBOH-BSA binding predicted on this basis is ϳ91%, which is higher than the 79% obtained by ultrafiltration, but the prediction is fairly sensitive to accuracy in the TBOH concentration data from the PSS-dextran experiment, in which the signal is quite small (Fig. 5) .
This study was carried out in anticipation of the use of these thiazine compounds to determine the effects of various interventions directed at determining the influence of physiological and/or pathophysiological stresses on these redox functions of the pulmonary endothelium within intact lungs. The results suggest that both MB and TBO have potential utility in this regard. However, the low K red for MB suggests that MB would be useful mainly for detecting substantial increases in K red , because any decrease would be barely detectable at normal flow rates. TBO may be more versatile because of the higher extraction. For studies in isolated lungs, the presence of albumin in the perfusate would be required to evaluate the role of the sequestration process in the overall disposition of TBO ϩ . The use of TBOH itself as test indicator might also be useful in this regard. The model should provide a tool for quantitative comparisons in such experiments, and it can also be used to provide a sense of the robustness of the quantification under a given set of experimental conditions.
APPENDIX
Estimation of TBOH Autoxidation Rate From Test Tube Experiments
For autoxidation of BH (and for BHP in PSS-albumin) within the perfusate solutions in the test tube, the temporal variation in the concentrations of the oxidized (B ϩ ) and reduced (BH) forms is described by the following
Under the assumption that when albumin is present the equilibration is rapid between the free and albumin-bound species, Eqs. A1-A4 reduce to 
